AI-Based Precision Transfusion Prediction Model in Critically Ill Patients (NCT07762131) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
AI-Based Precision Transfusion Prediction Model in Critically Ill Patients
2,598 participantsStarted 2026-09-01
Plain-language summary
This multicenter observational study aims to develop and validate an artificial intelligence-based precision transfusion prediction model for critically ill patients. The study will collect clinical characteristics, laboratory parameters, transfusion-related information, physiological data, and clinical outcomes from critically ill patients admitted to intensive care units. An AI model will be developed using retrospective data and further evaluated using prospective observational data. The primary objective is to investigate factors associated with multiple organ dysfunction syndrome (MODS) and establish a predictive model to support individualized transfusion management in critically ill patients.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients (aged ≥18 years) admitted to the intensive care unit.
* Patients with available clinical data, including demographic characteristics, laboratory parameters, transfusion-related information, and clinical outcomes.
* Patients meeting the requirements for model development and analysis.
Exclusion Criteria:
* Patients younger than 18 years.
* Patients with missing key clinical information required for analysis.
* Patients with repeated ICU admissions during the study period (only the first ICU admission will be included).
* Patients whose data cannot be used for research purposes according to ethical requirements.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Occurrence of Multiple Organ Dysfunction Syndrome (MODS)
Timeframe: During ICU hospitalization (up to 28 days after ICU admission)
Trial details
NCT IDNCT07762131
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine